High Tower Advisors, LLC Vir Biotechnology, Inc. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $15,938 - $18,748	-687 Reduced 5.47%	11,878 $291,000
Q1 2023 May 11, 2023	SELL	$22.26 - $30.85 $129,241 - $179,115	-5,806 Reduced 31.6%	12,565 $292,000
Q4 2022 Feb 08, 2023	BUY	$19.96 - $28.22 $366,685 - $518,429	18,371 New	18,371 $464,000
Q1 2022 May 12, 2022	SELL	$21.19 - $40.01 $107,009 - $202,050	-5,050 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$30.97 - $54.03 $290,653 - $507,071	-9,385 Reduced 65.02%	5,050 $211,000
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $503,781 - $787,284	14,435 New	14,435 $627,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $979M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.